NCT03035006 - Lipotecan Based Concurrent Chemoradiotherapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 14, 2017

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions

HepatoCellular CarcinomaPortal Vein Tumor Thrombosis

Interventions

DRUG

Lipotecan

Lipotecan based concurrent chemoradiotherapy

Trial Locations (4)

China Medical University Hospital, Taichung

Taichung Veterans General Hospital, Taichung

National Taiwan University Hosipital, Taipei

Taipei Veteran General Hospital, Taipei